Yijing Capital

Yijing Capital, established in 2015, is a professional investment institution with a long-term focus on advanced technology and life sciences. The firm operates with a philosophy of "global vision, value investment," aiming to be a participant in human progress. Beyond its core investment areas, Yijing Capital also strategically invests in smart manufacturing, medical and healthcare, TMT, and consumer products and services sectors.

Founded by Zhang Jianqun, who also chairs the industrial conglomerate Yizhou Group, Yijing Capital initially diversified its investments across new retail, education, and new media between 2015 and 2017. However, the firm progressively sharpened its focus on the healthcare and technology sectors after 2018, leading to an increased frequency of investments, peaking in 2021.

The firm manages assets exceeding 10 billion RMB and boasts a portfolio of over 90 companies, including 8 successful IPOs and 8 recognized unicorn enterprises. Notable investments in advanced technology include Leapmotor, Biren Technology, Lightelligence, Silang Technology, Qianxun Spatial Intelligence, Unisoc Communication, Zhiyue Space, and Yufeng Future. In the life sciences sector, key portfolio companies include Aopu Mai, MedSci, Dayi Group, Maibo Zhixing, and Oricell Therapeutics. Yijing Capital is also an active Limited Partner, managing a 1-billion-yuan fund of funds named "Wuxi Yijing," which has invested in numerous other venture capital firms.

Yijing Capital's core team leverages extensive investment experience to support entrepreneurs and portfolio companies in realizing their strategic and commercial potential. The firm's investment strategy has evolved to include early-stage investments, demonstrating a comprehensive approach to fostering innovation and growth across its target sectors.